|
| |
| | | 69924 | | 26.06.2025 | | Advanz Pharma Specialty Medicine Switzerland GmbH | | | | | | | 25.06.2030 | | | | | | | | | | 07.16.10. | | |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Eribulin Advanz Pharma 0.44 mg/ml | Injektionslösung | Injection solution (Eribulinum 0.88 mg) | L01XX41 | |
|
|
|
